Journal of Intellectual Property Law & Practice·May 30 · 04:15 UTC·Prof. Rebecca Eisenberg, Dr. Jorge Contreras
The Federal Circuit upheld a district court finding of obviousness in the Amgen v. Sanofi antibody patent dispute, reinforcing limits on broad functional claiming in the biopharmaceutical space. The court applied the Wan...
Stanford Technology Law Review·May 30 · 03:45 UTC·Dr. Andres Guadamuz, Meera Nair
A controlled empirical study from Stanford compared GPT-4o's prior art search performance against USPTO examiners across 400 randomly sampled applications in Class 705 (Data Processing: Financial, Business Practice). LLM...
GPT-4oprior art searchUSPTOpatent examinationempirical study
World Intellectual Property Review·May 29 · 22:10 UTC·Lena Hoffmann, Dr. Rudi Bekkers
As telecoms infrastructure transitions from 5G to nascent 6G architectures, standard-essential patent (SEP) holders—including Ericsson, Nokia, Qualcomm, and Huawei—are leveraging the transition window to renegotiate FRAN...
PLOS ONE – IP & Policy·May 29 · 18:30 UTC·Prof. Tenu Avafia, Dr. Srividhya Ragavan
Ongoing WHO Pandemic Treaty negotiations have surfaced deep tensions between high-income country IP frameworks—which prioritize pharmaceutical data exclusivity periods of 5–10 years—and low- and middle-income country dem...
WIPO Economic Research Working Papers·May 29 · 14:00 UTC·WIPO Economics & Statistics Division
WIPO's 2026 Global IP Filings Report documents a 41% year-over-year increase in patent applications where applicants disclosed AI tool involvement in the inventive process, concentrated among the top-50 filers by volume ...
IP Watchdog Research Series·May 29 · 11:45 UTC·Gene Quinn, Dr. Eileen McDermott
A survey of 312 patent attorneys across 18 jurisdictions reveals that 78% now use at least one generative AI tool in their IP practice, up from 31% in the 2024 equivalent survey. The most common use cases are claim draft...
